Antimicrobial activity evaluation and comparison of methods of susceptibility for Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacter spp. isolates
AUTOR(ES)
Rechenchoski, Daniele Zendrini, Dambrozio, Angélica Marim Lopes, Vivan, Ana Carolina Polano, Schuroff, Paulo Alfonso, Burgos, Tatiane das Neves, Pelisson, Marsileni, Perugini, Marcia Regina Eches, Vespero, Eliana Carolina
FONTE
Braz. J. Microbiol.
DATA DE PUBLICAÇÃO
2017-07
RESUMO
Abstract The production of KPC (Klebsiella pneumoniae carbapenemase) is the major mechanism of resistance to carbapenem agents in enterobacterias. In this context, forty KPC-producing Enterobacter spp. clinical isolates were studied. It was evaluated the activity of antimicrobial agents: polymyxin B, tigecycline, ertapenem, imipenem and meropenem, and was performed a comparison of the methodologies used to determine the susceptibility: broth microdilution, Etest® (bioMérieux), Vitek 2® automated system (bioMérieux) and disc diffusion. It was calculated the minimum inhibitory concentration (MIC) for each antimicrobial and polymyxin B showed the lowest concentrations for broth microdilution. Errors also were calculated among the techniques, tigecycline and ertapenem were the antibiotics with the largest and the lower number of discrepancies, respectively. Moreover, Vitek 2® automated system was the method most similar compared to the broth microdilution. Therefore, is important to evaluate the performance of new methods in comparison to the reference method, broth microdilution.
Documentos Relacionados
- Risk factors for KPC-producing Klebsiella pneumoniae bacteremia
- KPC-producing Enterobacter aerogenes infection
- Clinical and microbiological characterization of KPC-producing Klebsiella pneumoniae infections in Brazil
- Post-neurosurgical meningitis caused by KPC-producing Klebsiella pneumoniae: report of two cases
- Emergence of Klebsiella pneumoniae-producing KPC-2 carbapenemase in Paraíba, Northeastern Brazil